186 related articles for article (PubMed ID: 21861138)
21. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
[TBL] [Abstract][Full Text] [Related]
22. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
[TBL] [Abstract][Full Text] [Related]
23. Bernard-Soulier syndrome associated with 22q11.2 deletion and clinical features of DiGeorge/velocardiofacial syndrome.
Souto Filho JTD; Ribeiro HAA; Fassbender IPB; Ribeiro JMMC; Ferreira Júnior WDS; Figueiredo LCS
Blood Coagul Fibrinolysis; 2019 Dec; 30(8):423-425. PubMed ID: 31738289
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
25. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
26. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
[TBL] [Abstract][Full Text] [Related]
28. Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.
Schindewolf E; Khalek N; Johnson MP; Gebb J; Coleman B; Crowley TB; Zackai EH; McDonald-McGinn DM; Moldenhauer JS
Am J Med Genet A; 2018 Aug; 176(8):1735-1741. PubMed ID: 30055034
[TBL] [Abstract][Full Text] [Related]
29. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
[TBL] [Abstract][Full Text] [Related]
30. Congenital diaphragmatic hernia in 22q11.2 deletion syndrome.
Unolt M; DiCairano L; Schlechtweg K; Barry J; Howell L; Kasperski S; Nance M; Adzick NS; Zackai EH; McDonald-McGinn DM
Am J Med Genet A; 2017 Jan; 173(1):135-142. PubMed ID: 27682988
[TBL] [Abstract][Full Text] [Related]
31. [Graves disease and IgA deficiency as manifestations of 22q11.2 deletion syndrome].
Silva JM; Silva CP; Melo FF; Silva LA; Utagawa CY
Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):572-7. PubMed ID: 20857064
[TBL] [Abstract][Full Text] [Related]
32. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.
Yakut T; Kilic SS; Cil E; Yapici E; Egeli U
Pediatr Surg Int; 2006 Apr; 22(4):380-3. PubMed ID: 16463032
[TBL] [Abstract][Full Text] [Related]
33. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
[TBL] [Abstract][Full Text] [Related]
34. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour.
Beddow RA; Smith M; Kidd A; Corbett R; Hunter AG
Eur J Med Genet; 2011; 54(3):295-8. PubMed ID: 21187175
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of chromosomal abnormalities and 22q11.2 deletion in conotruncal and non-conotruncal antenatally diagnosed congenital heart diseases in a Chinese population.
Kong CW; Cheng YKY; To WWK; Leung TY
Hong Kong Med J; 2019 Feb; 25(1):6-12. PubMed ID: 30655461
[TBL] [Abstract][Full Text] [Related]
37. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.
Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM
J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525
[TBL] [Abstract][Full Text] [Related]
38. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
[TBL] [Abstract][Full Text] [Related]
39. A candidate gene approach to identify modifiers of the palatal phenotype in 22q11.2 deletion syndrome patients.
Widdershoven JC; Bowser M; Sheridan MB; McDonald-McGinn DM; Zackai EH; Solot CB; Kirschner RE; Beemer FA; Morrow BE; Devoto M; Emanuel BS
Int J Pediatr Otorhinolaryngol; 2013 Jan; 77(1):123-7. PubMed ID: 23121717
[TBL] [Abstract][Full Text] [Related]
40. Fetal phenotype associated with the 22q11 deletion.
Noël AC; Pelluard F; Delezoide AL; Devisme L; Loeuillet L; Leroy B; Martin A; Bouvier R; Laquerriere A; Jeanne-Pasquier C; Bessieres-Grattagliano B; Mechler C; Alanio E; Leroy C; Gaillard D
Am J Med Genet A; 2014 Nov; 164A(11):2724-31. PubMed ID: 25111715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
